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shortage of oxygen for the cardiac myocytes, fatty acid
metabolism is severely impaired.4 Oxygen deprivation
leads to a diminished b -oxidation of fatty acids, where-
as glucose competes favorably with fatty acids for the
residual oxygen, which is supplied to the heart in great-
ly reduced amounts.5 In addition, glycolytic activity is
enhanced, leading to the accumulation of lactate in
flow-deprived tissues.
In animal studies, reperfusion of cardiac tissue after a
relatively short period of ischemia resulted in rapid
restoration of the capacity to oxidize fatty acids.6-8
Restoration of flow after an ischemic interval longer
than 60 minutes was found to be associated with
depressed fatty acid oxidation and enhanced use of car-
bohydrates in the previously ischemic area.9 These find-
ings strongly suggest that the postischemic ability to
restore the ability of the cardiac muscle to handle fatty
U nder normal physiologic circumstances, cardiacmuscle uses fatty acids, lactate, and glucose as main
substrates to fulfill its energy requirements.1-3 During
restriction of coronary flow (ischemia) that leads to
Objective: This study was designed to clarify whether myocardial sub-
strate uptake and oxidation change after a period of hypothermic car-
dioplegic arrest during coronary artery bypass grafting procedures.
Methods: In 30 patients arterial and coronary sinus blood was sampled
and coronary sinus flow measurements were performed before and after
sternotomy and 10 minutes, 20 minutes, 50 minutes, and 6 hours after
release of the aortic crossclamp. Measurement of free fatty acids, lac-
tate, glucose, oxygen content, and carbon dioxide content in arterial and
coronary sinus blood allowed calculations of myocardial substrate use,
respiratory quotients, and myocardial oxidation rates of carbohydrates
and fat. Results: Uptake of free fatty acids and lactate was significant
throughout the study and did not change in association with release of
the crossclamp. Free fatty acid and lactate uptake measured 6 ± 4
m mol/min and 23 ± 26 m mol/min, respectively, before crossclamping
compared with 8 ± 7 m mol/min and 19 ± 21 m mol/min, respectively, after
release of the clamp. Glucose uptake was significant only during the first
hour after crossclamp release and increased from 7 ± 50 to 28 ± 34
m mol/L after crossclamp release. Myocardial oxygen consumption did
not change significantly (0.5 ± 0.2 mmol/L compared with 0.35 ± 0.2
mmol/L) after release of the crossclamp. Myocardial oxygen extraction
ratio decreased from 58% ± 8% to 41% ± 13% after crossclamp release.
Respiratory quotient increased after crossclamp release (0.85 ± 0.2 com-
pared with 1.00 ± 0.2), which implies that carbohydrate oxidation
increased at the expense of free fatty acid oxidation. Conclusion: We con-
clude that hypothermic cardioplegic arrest during coronary artery
bypass graft operations is associated with a transiently increased uptake
and oxidation of carbohydrates during the immediate reperfusion
phase. (J Thorac Cardiovasc Surg 1999;118:71-80)
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MYOCARDIAL SUBSTRATE UPTAKE AND OXIDATION DURING AND AFTER ROUTINE CARDIAC
SURGERY
acids depends on the severity of the preceding ischemic
episode.1
During cardiac surgery, aortic crossclamping results
in an almost complete cessation of blood flow through
the coronary arteries. Although measures are taken to
protect the myocardium by hypothermia and electro-
mechanical arrest, myocardial ischemia will occur.
Removal of the aortic crossclamp restores blood supply
to the heart and, hence, the delivery of molecular oxy-
gen and oxidizable substrates to the cardiac muscle
cells. At present, it is not clear whether the use of fatty
acids and glucose is immediately restored to preopera-
tive levels in the human heart after cardiac surgery.
Some studies indicated a normalization of fatty acid
uptake10 but a decline in oxidation in the first hours
after restoration of myocardial perfusion. Others, how-
ever, did not find a significant use of fatty acids and
carbohydrates after release of the aortic cross-
clamp.11,12
More knowledge of metabolic changes after myocar-
dial ischemia is necessary to optimize the treatment of
patients undergoing cardiac surgery. The aim of this
study is therefore to investigate whether substrate
uptake and oxidation of the heart changes after a peri-
od of hypothermic global ischemia during routine car-
diac surgery. For this purpose, metabolite, oxygen, and
carbon dioxide exchange across the heart was mea-
sured to investigate the exchange of fuels and to calcu-
late carbohydrate and fat oxidation from the respirato-
ry quotients. 
Methods
Patient population and selection. The patients in this
study had proved symptomatic coronary artery disease (New
York Heart Association classes III and IV) and had been
referred to a university hospital for operative revasculariza-
tion. Before the operation all patients were treated with b 1-
blocking agents and Ca++-reentry blockers. All other oral
medication was discontinued the evening before the opera-
tion. Only patients with preserved left ventricular function
(ejection fraction > 50%) were included in this study. Patients
with diabetes mellitus, thyroid diseases, hepatic insufficiency,
renal insufficiency, and therapy-resistant hypertension were
excluded from the study. Patients with heart failure and sig-
nificant cardiac valvular disorders and patients using sys-
temic corticosteroids were also excluded. The local ethical
review board approved the study. Written informed consent
was obtained from all patients.
Clinical management
Anesthesia. After overnight fasting, the patients were pre-
medicated with lorazepam (0.03-0.06 mg/kg). Anesthesia
was induced with midazolam (0.06-0.08 mg/kg), sufentanil
(1-1.5 m g/kg), and etomidate (0.2-0.3 mg/kg). Pancuronium
bromide (Pavulon, 0.1 mg/kg) was infused to induce muscle
relaxation. Anesthesia was maintained with sufentanil, 0.5
m g/kg per hour, before extracorporeal circulation (ECC), 2.5
m g/kg per hour during ECC, and 1.25 m g/kg per hour after
ECC. Nitroglycerin (0.5 m g/kg per minute) was started after
induction of anesthesia and was continued throughout the
operation. Postoperatively, patients were kept sedated with
midazolam. For postoperative analgesia, alfentanil (Rapifen,
2-3 mL/h) was given when necessary.
ECC. After sternotomy, heparin was given in a dose of 3
mg/kg. The ECC was performed with a roller pump (Stöckert
Shiley, Munich, Germany) giving a pulsatile flow and a hol-
low-fiber oxygenator (Capiox SX, Terumo Corp, Tokyo,
Japan). Moderate hypothermia (28°C-32°C) was routinely
applied during aortic crossclamping.
Cold crystalloid cardioplegic solution according to the St
Thomas’ Hospital method was used to arrest the heart13 via
the aortic root. Electrical silence of the heart was maintained
throughout the period of crossclamping. When the aortic
crossclamp time exceeded 60 minutes or electrical activity
occurred, extra cardioplegic solution (5-8 mL/kg) was given.
The solution contained (in millimoles per liter) sodium chlo-
ride (101.2), potassium chloride (16.2), magnesium sulphate
(1.3), magnesium chloride-6-hydrate (15.9), potassium
hydrogen phosphate (1.3), calcium chloride-2-hydrate (1.3),
procaine hydrochoride (1.1), and potassium bicarbonate (25).
ECC was terminated after rewarming to a rectal temperature
of 35°C. No inotropic drugs were used during weaning from
bypass. Protamine sulphate (3 mg/kg) was continuously
infused over 15 minutes immediately after weaning from
bypass to counteract the effect of heparin.
Study protocol. An arterial line was inserted in the left
radial artery. After induction of anesthesia, a pulmonary
artery catheter and a Baim coronary sinus thermodilution
catheter14 (7F) were inserted via the right internal jugular
vein. Under fluoroscopic control and continuous monitoring
of distal tip pressures, the coronary sinus catheter tip was
placed approximately 4 to 6 cm into the coronary sinus.
Correct positioning of the tip of the coronary sinus catheter
was verified by comparison of coronary sinus and mixed
venous blood oxygen saturation. This setting enabled us to
measure myocardial arteriovenous concentration differences
across the heart.
Hemodynamic measurements, coronary sinus blood flow,
and arterial and coronary sinus blood samples were taken
before (T1) and after (T2) incision and at the following times
after removal of the crossclamp: 10 minutes (T3), 20 minutes
(T4), 50 minutes (T5), and 6 hours (T6).
No cardiac output measurements were performed 10 min-
utes after removal of the crossclamp (T3) while patients were
being weaned from bypass. Measurements of gaseous
exchange were performed in a subgroup of 18 patients.
Because no differences were found between T1 and T2, the
data at these two times were pooled and compared with the
pooled data of T4 and T5. The data obtained 10 minutes after
removal of the crossclamp (T3) were omitted from the analy-
sis because during this measurement the hearts were being
weaned from ECC. The measured variance at this point was
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extremely high, making it likely that there was no intracellu-
lar steady state of substrates, which is a prerequisite to arrive
at reliable calculations and to acquire meaningful answers.
After transfer of the patients to the intensive care unit, the
position of the catheter in the coronary sinus was checked
again as described earlier.
Sample handling. Blood samples for biochemical analysis
were taken simultaneously from the radial artery and coro-
nary sinus. Samples for free fatty acids (FFAs) and glycerol
analysis were collected in ethylenediaminetetraacetic acid
tubes. Other samples were collected in sodium heparin tubes.
The samples were immediately centrifuged at 4°C, and the
plasma was frozen in liquid nitrogen and then stored at –80°C
until analysis. Before the lactate and glucose samples were
frozen, the protein was extracted from them by addition of 25
m L of a solution of trichloroacetic acid (5 g/10 mL) to 250 m L
of plasma.
Biochemical analysis. Total plasma FFA concentration
was determined with a Wako NEFA-C test kit (Wako
Chemicals, Neuss, Germany) on a COBAS BIO centrifugal
analyzer (Roche Diagnostics, Division of Hoffmann
LaRoche Ltd, Basel, Switzerland). Glucose was enzymatical-
ly determined on a COBAS MIRA with a test kit (Roche, The
Netherlands).15 Lactate was enzymatically determined on a
COBAS-MIRA with the use of lactate dehydrogenase
(Boehringer article number 127876).16 Blood oxygen satura-
tion was directly measured with an OSM3 Hemoximeter
(Radiometer A/S, Copenhagen, Denmark). Blood pH, carbon
dioxide tension (PCO2), and oxygen tension (PO2) were mea-
sured with an ABL-505 device (Radiometer). Arterial and
coronary sinus blood oxygen content was calculated from
these variables by means of the following formula: O2 con-
tent (mmol/L) = hemoglobin (Hgb) concentration (mmol/L)
· (HO2/Hgb) + 0.0105 · Po2 (kPa).
Total blood carbon dioxide content was directly measured
with a Finnigan MAT 252 GCC/IRMS mass spectrometer
(Finnigan Corporation, Division of ThermoQuest, San Jose,
Calif). Approximately 500 mg of blood was accurately
weighed into a 15-mL Vacutainer tube (Becton, Dickinson &
Company, East Rutherford, NJ). Carbon dioxide was liberat-
ed by addition of 0.5 mL sulphuric acid (1 mol/L) to the
blood sample, the head space gas mixture in the Vacutainer
tube was brought to atmospheric pressure by addition of heli-
um, and then 50 m L of the gas mixture was injected into a
Poroplot GC column (Chromopack International, Bergen op
Zoom, The Netherlands) connected on line to the IRMS mass
spectrometer. The carbon dioxide concentration was deter-
mined by simultaneous analyses of NaHCO3 standards of
known concentration. Hemoglobin and hematocrit values
were determined with a Coulter MAXM-AL (Coulter
Corporation, Mijdrecht, The Netherlands).
Flow measurements. Coronary sinus blood flow was mea-
sured by means of a retrograde continuous thermodilution
technique.14 Saline solution (0.9%) at room temperature was
infused with a Medrad Mark V infusion pump (Medrad, Inc,
Pittsburgh, Pa) at a rate of 50 mL/min for 30 seconds. Flow
measurements were performed before and after blood sam-
pling. The average of two measurements was taken to be rep-
resentative for the coronary sinus blood flow during the sam-
pling period.
Calculations. Net uptake and release of substrates, oxy-
gen, and carbon dioxide are calculated with the following
formula:
(Arterial concentration – Coronary sinus concentration) ·
Coronary sinus flow
Coronary sinus blood flow was used for variables deter-
mined in whole blood, whereas plasma flow was used for cal-
culation of fluxes of metabolites determined in plasma:
Plasma flow = (1 – Hematocrit) · Coronary sinus flow 
A positive number means uptake of substrate, and a nega-
tive number means release of substrate by the heart.
Extraction ratio. 
where a = arterial concentration and cs = coronary sinus con-
centration.
Respiratory quotient. 
Formulas used to calculate oxidation rates from myocardial
gaseous exchange and formulas used to calculate substrate
oxygen equivalents from myocardial substrate uptake are
given in the appendix.
Statistics. Data in tables and figures are given as mean ±
standard deviation of the mean. Wilcoxon matched-pairs
signed-ranks tests were used to test whether arterial–coronary
sinus substrate differences were significant. Analysis of vari-
ance was used to determine whether variables showed signif-
icant changes during the study period. Wilcoxon matched-
pairs signed-ranks tests were used as post hoc tests to
determine whether events showed significant changes. To
exclude that measured changes were due to surgical stress
and not to cold cardioplegic arrest, we made a comparison
The Journal of Thoracic and
Cardiovascular Surgery
Volume 118, Number 1
Pietersen et al   73
[a] – [cs] 
· 100% =
D [a – cs] 
· 100%[a] [a]
D [a – cs](CO2) · –1
D [a – cs](O2)
Table I. Characteristics of patients (n = 30; 25 male,
5 female) and operation conditions
Mean ± SD
Age (y) 61.7 ± 10.2
NYHA classification 3.0 ± 0.5
Number of grafts 3.7 ± 1.5
Crossclamp time (min) 40.0 ± 17.0
Volume of cardioplegic solution (mL) 695 ± 250
ECC time (min) 62 ± 20
ECC flow (L/min) 4.4 ± 0.4
Lowest blood temperature during ECC (°C) 27.7 ± 4
Lowest rectal temperature during ECC (°C) 32.6 ± 2
SD, Standard deviation; NYHA, New York Heart Association; ECC, extracor-
poreal circulation.
between T1 and T2. T2 was compared with T3 to evaluate
changes after a period of cold cardioplegic arrest. Because at
T3 the hearts were being weaned from ECC, a comparison
was made between T2 and the first measurement after car-
dioplegic arrest without support of ECC (T4). The changes in
the first hour after release of the crossclamp were studied by
comparing T3 versus T5. Finally, T1 was compared with T6
to investigate whether metabolism was normalized 6 hours
after release of the clamp. A Bonferroni correction for multi-
ple comparisons was performed to limit the possibility of false
positive significant changes (type I error) to 0.05 per variable
studied. The data calculated from gaseous exchange were ana-
lyzed in a similar way. Because these data were pooled, only
three periods were compared: before bypass, after bypass, and
6 hours after bypass. Bonferroni corrections were also made.
Results
Patient data (Table I). Patients were weaned from
ECC without serious complications. In two patients
defibrillation of the heart was necessary. No blood
samples were taken during periods of fibrillation.
Thirteen patients required temporary pacing with an
external pacemaker because of low heart rates after
weaning from ECC. Low peripheral resistance after
release of the crossclamp resulting in low mean arteri-
al blood pressures (mean arterial pressure < 60 mm Hg)
prompted the use of phenylephrine in seven patients. In
one of these patients, norepinephrine (5 m g/kg per
minute) was also given. The mean hematocrit value
was 0.35 ± 0.04 before bypass (T1 and T2) and
decreased to 0.24 ± 0.03 after bypass (T3). At the end
of the study period (T6), the hematocrit value was 0.28
± 0.05, which was lower than preoperative values.
Hemodynamic data (Table II). Pulmonary capillary
wedge pressures were at preoperative levels until
arrival in the postoperative intensive care unit.
Thereafter, pulmonary wedge pressure decreased. The
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Table II. Hemodynamic conditions (n = 30 patients) before, during, and up to 6 hours after CABG
Before incision After incision 15-20 + X-OFF 50 min + X-OFF 6 h + X-OFF 
(T1) (T2) (T4) (T5) (T6)
MAP (mm Hg) 77 ± 12 77 ± 14 69 ± 10 73 ± 10 75 ± 11
Wedge pressure (mm Hg) 12 ± 3.5 * 12 ± 3.6 13 ± 3.0 13 ± 3 9 ± 3
Cardiac index (L/min · m2) 2.3 ± 0.6 † 2.3 ± 0.6 ‡ 3.2 ± 0.7 3.2 ± 0.9 3.1 ± 0.7
SVR (dyne · s · m2/cm5) 2496 ± 755 † 2471 ± 714 ‡ 1541 ± 400 1701 ± 525 1839 ± 456
Rate pressure product (mm Hg/min) 4609 ± 1284 † 5344 ± 1745 5460 ± 938 5963 ± 1266 7075 ± 1815
CABG, Coronary artery bypass grafting; X-OFF, crossclamp off; MAP, mean arterial blood pressure; SVR, systemic vascular resistance.
*P = .03 T1 versus T6. 
†P < .001 T1 versus T6.
‡P < .001 T2 versus T4.
Table III. Arterial concentrations, extractions ratios, and net uptake of FFA, lactate, and glucose (n = 30 patients)
Before After X-OFF + X-OFF + X-OFF + X-OFF + 
incision incision 10 min 20 min 50 min 6 h 
(T1) (T2) (T3) (T4) (T5) (T6)
FFA arterial concentration (m mol/L) 384 ± 243 418 ± 243 § 422 ± 192 II 274 ± 189 200 ± 178 380 ± 157
FFA extraction ratio (%) 28 ± 9 23 ± 12 16 ± 12 16 ± 15 14 ± 13 28 ± 11
FFA uptake (m mol/min) 8 ± 6 6 ± 4 8 ± 7 6 ± 7 4 ± 5 12 ± 8
Lactate arterial concentration (mmol/L) 1.4 ± 0.5 ¶ 1.3 ± 0.5 1.4 ± 0.4 1.4 ± 0.4 1.3 ± 0.3 1.0 ± 0.3
Lactate extraction ratio (%) 31 ± 18 23 ± 30 14 ± 11 II 14 ± 13 21 ± 14 24 ± 13
Lactate uptake (m mol/min) 32 ± 22 23 ± 26 19 ± 21 II 24 ± 23.1 39 ± 27 26 ± 20
Glucose arterial concentration (mmol/L) 9.64 ± 2.4 # 10.14 ± 3.2 *‡ 8.14 ± 2.0 II 8.49 ± 2.3 8.37 ± 2.0 5.88 ± 1.0
Glucose extraction ratio (%) 0.5 ± 3.6 0.7 ± 4.4 3.3 ± 3.6 2.2 ± 3.8 0.9 ± 2.2 0.9 ± 3.3
Glucose uptake (m mol/min) 4 ± 24 7 ± 50 † 28 ± 34 ** 23 ± 38 ** 10 ± 25 ** 5 ± 16
X-OFF, Crossclamp off; FFA, free fatty acids. 
*P < .001 T2 versus T3.
†P = .025 T2 versus T3. 
‡P = .005 T2 versus T4.
§P = .015 T2 versus T4.
IIP < .001 T3 versus T5.
¶P = .01 T1 versus T6.
#P < .001 T1 versus T6.
**Significant glucose uptake.
rate pressure product (mean arterial blood pressure ·
heart rate) did not significantly change after release of
the crossclamp. Cardiac index increased after the
clamp was removed and was higher at the end of the
study period than before the operation.
Coronary sinus flow (Fig 1). Coronary sinus flow
increased after removal of the crossclamp and
remained elevated during the study period.
Substrate uptake and extraction by the heart
(Table III) 
FFA. The largest change in FFA arterial concentra-
tion occurred in the first hour after release of the aortic
crossclamp when protamine was given to counteract
the effects of heparinization (T3 vs T5). This resulted
in a decline of the arterial FFA concentration with
about 50%. FFA uptake by the heart was significant
throughout the study period. Incision and aortic cross-
clamping were not associated with significant changes
in FFA uptake. The mean FFA extraction ranged from
28% (T1) to 14% (T5).
Lactate. At the end of the study period the arterial
lactate concentration was lower than before the oper-
ation. Lactate uptake was significant throughout the
study period. Incision and aortic crossclamping did
not cause significant changes in lactate uptake.
Lactate uptake increased in the hour after release of
the aortic crossclamp (T3-T5). Mean lactate extrac-
tion ratio ranged from 31% (T1) to 14% (T3). After
crossclamp release, lactate extraction ratio increased
(T3-T5).
Glucose. After crossclamp release, the arterial glu-
cose concentration was lower than before crossclamp-
ing. At the end of the study period, arterial glucose con-
centration dropped below preoperative levels. The
mean glucose extraction ratio was low and ranged from
3% (T3) to 1% (T1). Glucose uptake was significantly
different from zero only during the first hour after
removal of the crossclamp. A significant increase in
glucose uptake was observed immediately after the
crossclamp was removed (T2 vs T3).
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Fig 1. Coronary sinus flow in 30 patients. P < .001: a, T1 ver-
sus T6; c, T2 versus T3; d, T2 versus T4.
Fig 2. Oxygen uptake and oxygen extraction ratio in 30
patients. c P < .001 = T2 versus T3; d P < .001 T2 versus T4;
e P = .01 T3 versus T5.
Oxygen uptake and extraction ratio by the heart
(Fig 2). Oxygen uptake did not significantly change
immediately after crossclamp removal (T3 and T4)
compared with values before crossclamping. In the first
hour after crossclamp release, oxygen uptake increased
(T3-T5). Oxygen uptake was not significantly different
from preoperative values at the end of the study period.
Mean oxygen extraction ratio was 58% to 60% before
and after incision. After crossclamp release, a decrease
was observed in oxygen extraction ratio compared with
values before aortic crossclamping. Oxygen extraction
ratio was not significantly different from preoperative
levels at the end of the study period.
Substrate oxygen equivalents (Fig 3). Fig 3 shows
the potential contribution of glucose, lactate, and FFA
taken up by the heart to myocardial oxygen consump-
tion, assuming that the substrates taken up are fully oxi-
dized. The potential contribution of FFA oxidation to
oxygen consumption ranged from 20% to 70%. A sig-
nificant decrease was seen in the first hour after removal
of the crossclamp. The potential contribution of lactate
oxidation to oxygen consumption ranged from 14% to
26% and did not change during the study period. The
potential contribution of glucose oxidation to oxygen
consumption ranged from 5% to 65% and increased
after crossclamp release (T2-T3). After removal of the
clamp, the sum of the potential contribution of oxida-
tion of all measured substrates was increased compared
with values before crossclamping. The sum immediate-
ly after release of the clamp (T3) was 156%, which was
significantly different from 100%, implying that more
substrates were taken up than could be oxidized. In the
hour after release of the clamp, this value decreased to
58% (T3 vs T5). At T1, T2, T5, and T6, the sum of the
calculated oxygen consumption was significantly small-
er than 100%, which implies that the measured net bal-
ance of substrate uptake could not account for all the
oxygen used by the heart.
Respiratory quotients and calculated oxidation
rates (Table IV). The respiratory quotient was 0.85 ± 0.2
before the clamp was applied (T1 and T2) and increased
to 1.00 ± 0.2 after release of the crossclamp (T4 and T5).
This also implies that release of the crossclamp was
associated with a shift to carbohydrate oxidation.
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Fig 3. Substrate oxygen equivalents (VO2equivalents) in 30 patients as a percentage of the measured VO2a–cs. The
calculations are made under the assumption that all substrates taken up by the heart are fully oxidized. a P < .001,
glucose T2 versus T3; b P = .02, FFA T3 versus T5; c P <.001, total VO2equivalents/VO2a–cs, T2 versus T3; d P
< .001, total VO2equivalents/VO2a–cs, T3 versus T5; #P < .05, total VO2equivalents/VO2a–cs significantly differ-
ent from 100%.
Discussion
The data in this study show that FFAs and lactate were
the main fuels of the human heart in the period before
coronary artery bypass graft (CABG) operations and 6
hours after removal of the aortic crossclamp. Glucose
was only a minor fuel in both periods. This implies that
the metabolism of these hearts was comparable with the
metabolism of healthy human hearts, as previously
reported.3 A clear change occurred in the first hour after
CABG surgery. In that period the heart extracted more
glucose (see arteriovenous balance in Table III) and oxi-
dized more carbohydrate and less fat (see cardiac respi-
ratory quotient data in Table IV) than in the preoperative
period and 6 hours after CABG surgery. This transient
period of increased glucose uptake and carbohydrate
oxidation was accompanied by an increase in cardiac
blood flow and a decrease in fractional oxygen extrac-
tion. Immediately after removal of the aortic cross-
clamp, more substrates were extracted by the heart than
oxidized, indicating that there was a net accumulation
of energy-rich substrates in the heart in that period.
Even in relatively healthy hearts protected with cold
cardioplegic solution, we observed a hyperemic
response in combination with decreased myocardial
oxygen extraction after release of the aortic crossclamp.
In the past these disturbances have been suggested to
involve general mitochondrial dysfunction17,18 or even
mitochondrial damage, arising during reperfusion of the
previously ischemic cardiac tissue.17,18
The increased glucose uptake observed in this study
is in agreement with experimental studies of myocar-
dial metabolism after ischemia in animal models7,19-21
in which an increased glucose uptake was found after
ischemia. The data also confirm the study of Teoh and
associates,10 who found a decreased FFA oxidation in
the first hour after crossclamp removal during cardiac
surgery.
The observation made in this study that glucose is the
preferential fuel in the first hour after CABG surgery
strengthens the rationale for the clinical use of glucose-
insulin infusions after cardiac operations.22,23 The
patients in this study had good left ventricular function
and recovered quickly from the operation. The prefer-
ential use of glucose may be more pronounced and
even be more essential for functional recovery of the
heart in patients in whom cardiac function is reduced
both before and after CABG. The observations made
here may imply that the hyperemia of the heart after
CABG serves to provide more of the preferential fuel
(glucose) to the heart. This mechanism may be defec-
tive in hearts with reduced postoperative function.
Glucose-insulin infusions in that case may provide
important metabolic support and may help to improve
postoperative cardiac function. When a temporary
energy deficit in the first hour after CABG is the cause
for the increase in blood flow and glucose uptake and
when the energy problem is related to a suboptimal tri-
carboxylic acid cycle flux,24,25 then glutamate infu-
sions could also form part of the metabolic strategies to
support the heart after CABG surgery.22,23
An alternative explanation for the change in substrate
uptake and oxidation of the heart, not related to a tem-
porary energy problem in the myocardial cells, is a
change in substrate supply to the heart. In this study a
decrease of FFA arterial concentration was observed
after crossclamp removal. The arterial FFA concentra-
tion and the concentration gradient between the blood
and cardiac tissue is a major determinant of FFA uptake
and oxidation by the human heart.4 The decrease in
arterial FFA concentration, therefore, can be a cause
for the decrease in fat oxidation by the heart. This
decrease in fat oxidation may, via the glucose–FFA
cycle,4,26 also lead to the increase in glucose uptake and
carbohydrate oxidation. An argument against this
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Table IV. Data of gaseous exchange across the heart and calculations of carbohydrate and FFA oxidation in 18
patients (see appendix for formulas)
Before X-ON (T1, T2) After X-OFF (T4, T5) X-OFF + 6 h (T6)
VCO2a–cs (m mol/L blood) –3715 ± 825 *‡ –2571 ± 661 –2844 ± 503
VO2a–cs (m mol/L blood) 4392 ± 600 *‡ 2591 ± 401 3286 ± 503
Respiratory quotient 0.85 ± 0.2 † 1.00 ± 0.2 0.88 ± 0.2
Carbohydrate oxidation as percentage of VO2a–cs 51 ± 61 † 101 ± 78 59 ± 52
FFA oxidation as percentage of VO2a–cs 49 ± 61 † –1 ± 78 41 ± 52
Carbohydrate oxidation (m mol/min) 46 ± 57 † 71 ± 53 51 ± 47
FFA oxidation (m mol/min) 10 ± 14 † 1 ± 13 9 ± 11
FFA, Free fatty acids; X-ON, crossclamp on; X-OFF, crossclamp off; a, arterial concentration; cs, coronary sinus concentration.
*P < .001 before X-ON versus after X-OFF.
†P = .03 before X-ON versus after X-OFF.
‡P < .001 before X-ON versus X-OFF + 6 hours.
mechanism is that during the first measurement after
crossclamp release, when glucose uptake reached peak
levels, the FFA arterial concentration was similar to
values before the clamp was applied.
The accuracy of coronary sinus flow as a measure of
myocardial perfusion depends on the position of the
catheter within the coronary sinus.27 A shift in catheter
position will cause a change in measured flow. This
limits the use of coronary sinus flow in comparing
changes between individuals. However, the method has
been proved accurate in recording changes within a
studied subject.14 In this study special care was given to
verify correct position of the catheter in the coronary
sinus. The surgeon digitally checked the position of the
catheter within the coronary sinus, thus excluding
major errors resulting from catheter dislodgment.
Small changes in catheter position cannot be excluded
and may be a cause of the relatively large variance of
the measurements. The changes we observed in flow
were large and were consistently observed in all
patients. The large changes in combination with the
careful check of correct catheter position lead us to
believe that the observed changes are a correct reflec-
tion of changes in myocardial perfusion.
Before the operation and between 2 and 6 hours after
CABG, the myocardial substrate uptake (sum of FFAs,
lactate, and glucose) did not fully account for the
amount of oxygen used by the heart (Fig 3). Other com-
pounds, which may have been oxidized, are ketone
bodies and amino acids (minimal exchange only, data
not shown). A potentially important fuel also are the
fatty acids present in the triglycerides of very low den-
sity lipoprotein. These are liberated by lipoprotein
lipase present on the membrane of the endothelial cells
of the cardiac vascular bed.4 In the first eight patients
we did not observe a significant arteriovenous differ-
ence for the plasma total triglyceride concentration and
for the glycerol concentration (liberated during lipoly-
sis) and, therefore, we did not attempt to quantitate the
plasma triglyceride contribution in subsequent studies.
However, the sum of these additional substrates, which
are difficult to quantitate individually, may well cover
the missing substrate oxidation in Fig 3.
This study shows that glucose is the preferential fuel
of the human heart in the first hour after CABG
surgery, whereas fatty acids and lactate are the main
fuels before and 6 hours after CABG surgery, as in nor-
mal healthy hearts. There also is an increase in coro-
nary blood flow in the first hour after CABG surgery,
which may function to supply more of the preferential
substrate to the heart. This finding seems to support the
clinical use of glucose-insulin infusions to support the
energy metabolism of the heart after CABG surgery.
Further research is needed to investigate the underlying
mechanism of the parallel increase in glucose uptake
and coronary blood flow, because it may provide new
information regarding metabolic strategies that can be
used to support the human heart in the postoperative
period.
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Appendix
Gaseous exchange. The measurement of oxygen uptake
and carbon dioxide production across tissue beds yields
information regarding the nature and quantity of the sub-
strates oxidized in these tissues. Formulas were used as
described by Frayn and associates.28,29 When glucose is oxi-
dized according to the equation
Glucose (C6H12O6) + 6 O2 fi 6 H2O + 6 CO2 (Eq1)
6 moles of oxygen are consumed and 6 moles of carbon diox-
ide are produced for each mole of glucose that is oxidized.
The respiratory quotient is then 1.0. The oxidation of lactate
according to the equation
Lactate (C3H6O3) + 3 O2 fi 3 H2O + 3 CO2
also gives a respiratory quotient of 1.0. The formulas subse-
quently given provide information about the net oxidation of
carbohydrates in the heart, which will be the sum of glucose
and lactate oxidation. It is assumed that FFAs rather than tri-
acylglycerols are oxidized in the myocardium. For simplicity
the average of oleic acid (C18H34O2) and stearic acid
(C18H36O2) will be considered; that is, C18H35O2. The equa-
tion for complete FFA oxidation is:
4 C18H35O2 + 103 O2 + 72 CO2 + 70 H2O 
(respiratory quotient = 0.699) (Eq2)
The oxidation of amino acids in the myocardium can be
estimated from the myocardial nitrogen release. However, it
has been shown that the quantitative contribution of amino
acids to energy contribution in the heart is small.30 Therefore,
the contribution of amino acids was neglected. This means
that if oxygen and carbon dioxide content in arterial and coro-
nary sinus blood (VO2a–cs and VCO2a–cs) are known, the rel-
ative contribution of carbohydrates and FFAs can be calculat-
ed from two formulas with two unknown parameters. If the
oxidation rate of glucose per liter blood flow is G (m mol/L)
and the FFA oxidation per liter blood flow is F (m mol/L), then:
VO2a–cs (m mol/L) = 6 · G + (103/4) · G (Eq3)
VCO2a–cs (m mol/L) = 6 · G + (72/4) · F (Eq4)
These equations can be converted into:
G (m mol/L) = 0.553 · VCO2a–cs - 0.387 · VO2a–cs (Eq6)
F (m mol/L) = 0.129 · (VO2a–cs - VCO2a–cs) (Eq7)
The relative contribution of carbohydrate and FFA oxida-
tion to oxygen consumption can be derived from these for-
mulas. These relative contributions are independent of the
measured coronary sinus flow (see also Table IV).
Relative contribution of glucose to VO2a–cs = 100 ·
(G · 6)/(O2a–cs) (Eq8)
Relative contribution of FFA to VO2a–cs = 100 ·
(F · 25.7)/(O2a–cs) (Eq9)
Multiplying formulas (6) and (7) with the coronary sinus
blood flow in liters per minute gives the absolute oxidation
rate of carbohydrates and FFAs in micromoles per minute
(see also Table IV):
Glucose oxidation rate (m mol/m) = G (m mol/L) ·
cs flow (L/m) (Eq10)
FFA oxidation rate (m mol/m) = F (m mol/L) ·
cs flow (L/m) (Eq11)
Substrate oxygen equivalents (VO2equivalents). To assess
whether oxidation of FFAs, glucose, and lactate could explain
the amount of oxygen taken up by the heart, we calculated the
amount of oxygen necessary for full oxidation of these three
substrates. The oxygen equivalents of these substrates taken
up were calculated by multiplying the arterial–coronary sinus
difference of the substrate extracted with the amount of oxy-
gen necessary for full oxidation of the substrate and the fac-
The Journal of Thoracic and
Cardiovascular Surgery
Volume 118, Number 1
Pietersen et al   79
tor (1 – hematocrit). The correction for hematocrit was nec-
essary to enable the comparison of arterial–coronary sinus
differences measured in plasma (glucose, lactate, and FFAs)
with arterial–coronary sinus differences measured in whole
blood (oxygen). It was assumed that the oxidation of 1 mol of
FFA uses 25.7 mol of oxygen, 1 mol of lactate uses 3 mol of
oxygen, and 1 mol of glucose uses 6 mol of oxygen. These
oxygen equivalents were then expressed as a percentage of
the measured O2a–cs. The calculated figures have no dimen-
sion and are flow independent. As an example, the formula
for the glucose oxygen equivalent as percentage of measured
O2a–cs (GO2eq%)is given (see also Fig 3).
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G
o2eq% =
Glucose uptake (m mol/min) (Ga–cs · [1 – Hct] · cs flow)
O2 consumption (m mol/min) (O2a–cs · cs flow)
· 100% (Eq12)
G
o2eq% =
Glucose a–cs (m mol/L) · (1 – Hct) · 6
· 100%
O2a–cs (m mol/L)
(Eq13)
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